Stockreport

SNGX: Agreement with EMA on Second Confirmatory Trial for HyBryte™… [Yahoo! Finance]

Soligenix, Inc.  (SNGX) 
NASDAQ:AMEX Investor Relations: soligenix.com/investors
PDF Reaches Agreement with European Medicines Agency on Second Confirmatory Trial for HyBryte™ On April 3, 2024, Soligenix, Inc. (NASDAQ:SNGX) announced it has reached ag [Read more]